TVTX - Travere Therapeutics, Inc.
28.63
-0.350 -1.222%
Share volume: 868,325
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$28.98
-0.35
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-06-2024 | 08-01-2024 | 10-31-2024 | 02-21-2025 | 05-01-2025 | 08-06-2025 | 10-30-2025 | 02-19-2026 | |
| Total revenue | 41.374 M | 54.116 M | 62.898 M | 74.787 M | 81.732 M | 114.449 M | 164.859 M | 129.688 M | |
| Cost of revenue | 1.504 M | 2.061 M | 1.626 M | 2.553 M | 4.679 M | 1.521 M | 1.585 M | 2.554 M | |
| Gross profit | 39.870 M | 52.055 M | 61.272 M | 72.234 M | 77.053 M | 112.928 M | 163.274 M | 127.134 M | |
| 30.56% | 17.71% | 17.89% | 6.67% | 46.56% | 44.58% | -22.13% | |||
| Operating expenses | 178.848 M | 119.106 M | 117.298 M | 131.568 M | 119.727 M | 125.578 M | 138.343 M | 159.565 M | |
| Selling general and admin | 64.223 M | 64.776 M | 65.619 M | 69.501 M | 72.838 M | 76.216 M | 86.453 M | 101.695 M | |
| Research and development | 114.625 M | 54.330 M | 51.679 M | 62.067 M | 46.889 M | 49.362 M | 51.890 M | 57.870 M | |
| Total expenses | 179.107 M | 119.759 M | 117.421 M | 132.971 M | 119.727 M | 125.578 M | 138.343 M | 159.565 M | |
| -33.14% | -1.95% | 13.24% | -9.96% | 4.89% | 10.16% | 15.34% | |||
| Operating income | -139.237 M | -67.704 M | -56.149 M | -60.737 M | -42.674 M | -12.650 M | 24.931 M | -32.431 M | |
| Ebit | -138.999 M | -71.199 M | -55.629 M | -61.318 M | -42.125 M | -13.176 M | 25.418 M | -21.363 M | |
| Pretax income | -135.767 M | -69.567 M | -54.836 M | -60.340 M | -41.187 M | -12.735 M | 25.714 M | -21.065 M | |
| -48.76% | -21.18% | 10.04% | -31.74% | -69.08% | -301.92% | -181.92% | |||
| Income tax | 191.000 K | 85.000 K | -84.000 K | -72.000 K | 39.000 K | 20.000 K | 8.000 K | 921.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -136.061 M | -70.409 M | -54.811 M | -60.264 M | -41.226 M | -12.755 M | 25.706 M | 2.729 M | |
| 48.25% | 22.15% | -9.95% | 31.59% | 69.06% | 301.54% | -89.38% |